Beryl Drugs Limited (BERLDRG.BO)
INR 19.55
(-3.65%)
INR 19.55
(-3.65%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 14.73 Million INR | 23.56% |
| 2022 | 11.92 Million INR | 282.25% |
| 2021 | -6.54 Million INR | -428.96% |
| 2020 | 1.98 Million INR | -26.72% |
| 2019 | 2.71 Million INR | -62.6% |
| 2018 | 7.25 Million INR | -0.34% |
| 2017 | 7.28 Million INR | 264.54% |
| 2016 | -4.42 Million INR | -520.64% |
| 2015 | 1.05 Million INR | -71.63% |
| 2014 | 3.7 Million INR | -39.15% |
| 2013 | 6.09 Million INR | -12.27% |
| 2012 | 6.94 Million INR | 267.57% |
| 2011 | 1.88 Million INR | -11.25% |
| 2010 | 2.12 Million INR | -9.38% |
| 2009 | 2.34 Million INR | 62.26% |
| 2008 | 1.44 Million INR | -29.67% |
| 2007 | 2.05 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 6.65 Million INR | 329.93% |
| 2023 Q2 | 4.23 Million INR | -50.24% |
| 2023 Q3 | 4.88 Million INR | 15.5% |
| 2023 Q1 | 8.5 Million INR | 606.98% |
| 2023 FY | 14.73 Million INR | 23.56% |
| 2023 Q4 | -2.89 Million INR | -159.19% |
| 2022 Q4 | 1.2 Million INR | -75.7% |
| 2022 FY | 11.92 Million INR | 282.25% |
| 2022 Q1 | 3.47 Million INR | 162.21% |
| 2022 Q2 | 4.36 Million INR | 25.48% |
| 2022 Q3 | 4.95 Million INR | 13.48% |
| 2021 Q3 | -268 Thousand INR | 92.07% |
| 2021 Q4 | -5.58 Million INR | -1985.45% |
| 2021 FY | -6.54 Million INR | -428.96% |
| 2021 Q1 | 4.1 Million INR | 8102.0% |
| 2021 Q2 | -3.37 Million INR | -182.39% |
| 2020 Q1 | -360 Thousand INR | 92.83% |
| 2020 FY | 1.98 Million INR | -26.72% |
| 2020 Q3 | -1.76 Million INR | -130.98% |
| 2020 Q4 | 50 Thousand INR | 102.84% |
| 2020 Q2 | 5.69 Million INR | 1680.83% |
| 2019 Q2 | 2.54 Million INR | -47.41% |
| 2019 FY | 2.71 Million INR | -62.6% |
| 2019 Q1 | 4.83 Million INR | 782.82% |
| 2019 Q3 | 2.57 Million INR | 1.38% |
| 2019 Q4 | -5.02 Million INR | -294.76% |
| 2018 Q4 | 547.9 Thousand INR | -80.23% |
| 2018 Q3 | 2.77 Million INR | -11.95% |
| 2018 FY | 7.25 Million INR | -0.34% |
| 2018 Q1 | 2.91 Million INR | -71.47% |
| 2018 Q2 | 3.14 Million INR | 7.92% |
| 2017 Q1 | 1.66 Million INR | 250.21% |
| 2017 Q4 | 10.22 Million INR | 565.43% |
| 2017 Q3 | 1.53 Million INR | 4.14% |
| 2017 FY | 7.28 Million INR | 264.54% |
| 2017 Q2 | 1.47 Million INR | -11.14% |
| 2016 Q1 | 1.95 Million INR | 357.09% |
| 2016 FY | -4.42 Million INR | -520.64% |
| 2016 Q4 | 474 Thousand INR | 237.79% |
| 2016 Q3 | -344 Thousand INR | -119.62% |
| 2016 Q2 | 1.75 Million INR | -10.52% |
| 2015 Q3 | 1.05 Million INR | -57.99% |
| 2015 Q4 | -762 Thousand INR | -172.3% |
| 2015 Q2 | 2.5 Million INR | 33.53% |
| 2015 FY | 1.05 Million INR | -71.63% |
| 2015 Q1 | 1.87 Million INR | 200.14% |
| 2014 Q4 | -1.87 Million INR | -214.98% |
| 2014 FY | 3.7 Million INR | -39.15% |
| 2014 Q1 | 1.49 Million INR | 169.92% |
| 2014 Q2 | 2.45 Million INR | 63.71% |
| 2014 Q3 | 1.63 Million INR | -33.5% |
| 2013 Q2 | 2.07 Million INR | -6.54% |
| 2013 FY | 6.09 Million INR | -12.27% |
| 2013 Q1 | 2.21 Million INR | 217.04% |
| 2013 Q3 | 2.26 Million INR | 9.31% |
| 2013 Q4 | -2.14 Million INR | -194.65% |
| 2012 Q1 | 2.93 Million INR | 126.43% |
| 2012 Q4 | -1.89 Million INR | -159.64% |
| 2012 FY | 6.94 Million INR | 267.57% |
| 2012 Q3 | 3.17 Million INR | 16.17% |
| 2012 Q2 | 2.73 Million INR | -6.72% |
| 2011 FY | 1.88 Million INR | -11.25% |
| 2011 Q4 | -11.08 Million INR | -653.65% |
| 2011 Q3 | 2 Million INR | 0.0% |
| 2010 FY | 2.12 Million INR | -9.38% |
| 2009 FY | 2.34 Million INR | 62.26% |
| 2008 Q4 | 721 Thousand INR | 0.0% |
| 2008 FY | 1.44 Million INR | -29.67% |
| 2007 FY | 2.05 Million INR | 0.0% |
| 2007 Q4 | -3.73 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -2670.214% |
| Sastasundar Ventures Limited | -229.64 Million INR | 106.415% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 139.018% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 85.069% |
| Vasundhara Rasayans Limited | 61.27 Million INR | 75.958% |
| Sunil Healthcare Limited | -19.98 Million INR | 173.73% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | 10.362% |
| MedPlus Health Services Limited | 1.31 Billion INR | 98.884% |
| Zenith Healthcare Limited | 196 Thousand INR | -7416.327% |
| Patidar Buildcon Limited | -1.83 Million INR | 902.397% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | 77.149% |
| Roopa Industries Limited | 48.05 Million INR | 69.345% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Trident Lifeline Limited | 72.21 Million INR | 79.599% |
| Bacil Pharma Limited | -1.89 Million INR | 877.685% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 109.867% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | -63.871% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 109.203% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | 13.974% |
| PANJON LTD. | - INR | -Infinity% |
| Tyche Industries Limited | 111.22 Million INR | 86.755% |
| Trimurthi Limited | -6.14 Million INR | 339.816% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 182.224% |
| Anuh Pharma Limited | 682.19 Million INR | 97.841% |
| Crestchem Limited | 27.25 Million INR | 45.949% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 225.325% |
| Zenlabs Ethica Limited | 89.27 Million INR | 83.499% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 95.66% |
| ANG Lifesciences India Limited | 12.8 Million INR | -15.049% |
| Parmax Pharma Limited | 3.75 Million INR | -292.377% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 95.956% |
| Deccan Health Care Limited | 185.32 Million INR | 92.051% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 93.765% |
| Norris Medicines Limited | 11.15 Million INR | -32.041% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 93.169% |
| Veerhealth Care Limited | 34.19 Million INR | 56.914% |
| Makers Laboratories Limited | -34.91 Million INR | 142.2% |
| Lactose (India) Limited | 137.78 Million INR | 89.308% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 111.922% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 96.627% |
| Mercury Laboratories Limited | 62.14 Million INR | 76.295% |
| Gennex Laboratories Limited | 146.61 Million INR | 89.952% |
| PRAVEG LIMITED | 185.06 Million INR | 92.04% |
| Denis Chem Lab Limited | 142.87 Million INR | 89.689% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 97.058% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 97.798% |
| Colinz Laboratories Limited | 14.64 Million INR | -0.608% |
| Godavari Drugs Limited | -67.67 Million INR | 121.77% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 3728.571% |
| Zenotech Laboratories Limited | 242.37 Million INR | 93.922% |
| Panchsheel Organics Limited | 288.28 Million INR | 94.89% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 97.427% |
| Vivanza Biosciences Limited | 14.83 Million INR | 0.674% |
| Phaarmasia Limited | - INR | -Infinity% |
| Bharat Parenterals Limited | 733.49 Million INR | 97.992% |
| Medi-Caps Limited | -17.21 Million INR | 185.601% |
| DECIPHER LABS LIMITED | 53.74 Million INR | 72.587% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 98.275% |
| BDH Industries Limited | 169.01 Million INR | 91.284% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 245.186% |
| Coral Laboratories Limited | 142.63 Million INR | 89.671% |
| Concord Drugs Limited | 24.87 Million INR | 40.769% |
| Evoq Remedies Limited | 42.91 Million INR | 65.673% |
| Add-Shop E-Retail Limited | 77.57 Million INR | 81.008% |
| Transchem Limited | -17.43 Million INR | 184.477% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | -84.89% |
| Parnax Lab Limited | 166.84 Million INR | 91.17% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | 56.867% |
| Kerala Ayurveda Limited | 48.04 Million INR | 69.338% |
| Cian Healthcare Limited | 53.96 Million INR | 72.703% |
| Trinity League India Limited | 1.17 Million INR | -1155.925% |
| Syschem (India) Limited | 504.91 Million INR | 97.082% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 694.032% |
| Natural Capsules Limited | 112.4 Million INR | 86.893% |
| Auro Laboratories Limited | 95.77 Million INR | 84.618% |